UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases

Annals of the rheumatic diseases, 2009-12, Vol.68 (12), p.1863-1869

2009

Volltextzugriff (PDF)

Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2006-07, Vol.65 (7), p.889-894

2006

Volltextzugriff (PDF)

AB0523 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS AT 56 WEEKS FROM THE SELECT-PsA 1 STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1288-1289

2021

Volltextzugriff (PDF)

LB0001 EFFICACY AND SAFETY OF UPADACITINIB VERSUS PLACEBO AND ADALIMUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NON-BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PsA-1): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.16-17

2020

Volltextzugriff (PDF)

OP0036 A phase 3 randomised, placebo-controlled, double-blind study of upadacitinib (ABT-494), a selective jak-1 inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic dmards

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.68

2018

Volltextzugriff (PDF)

OP0334 Efficacy and safety of continuing versus withdrawing adalimumab (ADA) in maintaining remission in patients with non-radiographic axial spondyloarthritis (NR-AXSPA)

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.213

2018

Volltextzugriff (PDF)

SAT0255 Patient reported outcomes of upadacitinib: results from biologic inadequate responders (SELECT BEYOND PHASE III TRIAL)

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.990

2018

Volltextzugriff (PDF)

OP0035 Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.67

2018

Volltextzugriff (PDF)

SAT0254 Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs: results from select-next

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.989

2018

Volltextzugriff (PDF)

SAT0219 Upadacitinib in patients with active rheumatoid arthritis and inadequate response or intolerance to biological dmards: a phase 3 randomized, placebo-controlled, double-blind study of a selective jak1 inhibitor

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.970

2018

Volltextzugriff (PDF)

Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis

Annals of the rheumatic diseases, 2008-09, Vol.67 (9), p.1218-1221

2008

Volltextzugriff (PDF)

FRI0438 Disease management of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients is similar in academic and community practice among 654 surveyed rheumatologists

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A523-A523

2013

Volltextzugriff (PDF)

FRI0440 Referral patterns and diagnosis of patients with axial spondyloarthritis: results of an international survey

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A524-A524

2013

Volltextzugriff (PDF)

AB1158 Quality of Life in Patients with Active Peripheral SPA is Similarly Impaired as in Other Rheumatic Diseases and Influenced by Disease Activity But not Disease Duration

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1290-1290

2015

Volltextzugriff (PDF)

THU0359 Smoking was not Associated with Response to Adalimumab Therapy in Patients with Non-Radiographic Axial Spondyloarthritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A286-A286

2013

Volltextzugriff (PDF)

SAT0339 Asas40 and ASDAS Responses Are Associated with Improved Physical Function, Hrqol, and Work Productivity in Patients with Non-Radiographic Axial Spondyloarthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.715-715

2014

Volltextzugriff (PDF)

OP0109 Sustained Clinical Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Two Years of Adalimumab Treatment

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A88-A88

2013

Volltextzugriff (PDF)

THU0361 Relationship between MRI and Clinical Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Two Years of Adalimumab Therapy

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A287-A287

2013

Volltextzugriff (PDF)

FRI0425 Similar levels of disease activity in patients with oligoarticular vs. polyarticular peripheral spondyloarthritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A518-A518

2013

Volltextzugriff (PDF)

Application of Retort Pouch Sterilization Technology to DD Satoe Packaged Chili Sauce Surabaya

Journal of innovation and applied technology (Online), 2023-12, Vol.9 (2), p.114-119

Ali, Dego Yusa

2023

Volltextzugriff (PDF)

OP0105 Effect of Adalimumab on Physical Function, Health-Related Quality of Life, and Work Productivity in Patients with Peripheral Spondyloarthritis: Results from the Ability-2 Clinical Trial

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A86-A86

2013

Volltextzugriff (PDF)

PREFERENSI KONSUMEN TERHADAP EMPAT VARIETAS UNGGUL MANGGA INDONESIA BERDASARKAN RESPON EMOSI

Jurnal Teknologi dan Industri Pangan (Edisi), 2021-12, Vol.32 (1), p.116-125

2021

Volltextzugriff (PDF)

KARAKTERISTIK FISIKOKIMIA DAN SENSORI BERAS ANALOG MULTIGRAIN BERPROTEIN TINGGI

Jurnal Teknologi dan Industri Pangan (Edisi), 2021-06, Vol.32 (1), p.60-71

2021

Volltextzugriff (PDF)

KARAKTERISASI KEJU DANGKE MENGGUNAKAN ENZIM PAPAIN KOMERSIAL DAN PERUBAHAN FISIK SELAMA PENYIMPANAN

Jurnal Teknologi dan Industri Pangan (Edisi), 2021-06, Vol.32 (1), p.27-35

2021

Volltextzugriff (PDF)

ISOLASI PROTEIN KACANG MERAH DAN KACANG HIJAU MENGGUNAKAN METODE ASAM BASA DIKOMBINASIKAN DENGAN PROSES ENZIMATIS

Jurnal Teknologi dan Industri Pangan (Edisi), 2021-12, Vol.32 (1), p.157-168

2021

Volltextzugriff (PDF)

1 – 25 von 759

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(425)
Mit Volltextzugriff
(367)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(200)
Life Sciences & Biomedicine
(138)
Humans
(61)
Technology
(60)
Female
(47)
Male
(46)
Rheumatology
(45)
Engineering
(41)
Adult
(37)
Engineering, Electrical & Electronic
(36)
Telecommunications
(36)
Rheumatoid Arthritis
(35)
Middle Aged
(33)
Mimo
(32)
Patients
(30)
Antirheumatic Agents - Therapeutic Use
(28)
Arthritis
(27)
Double-Blind Method
(27)
Treatment Outcome
(25)
Adalimumab
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases

Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis

AB0523 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS AT 56 WEEKS FROM THE SELECT-PsA 1 STUDY

LB0001 EFFICACY AND SAFETY OF UPADACITINIB VERSUS PLACEBO AND ADALIMUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NON-BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PsA-1): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL

OP0036 A phase 3 randomised, placebo-controlled, double-blind study of upadacitinib (ABT-494), a selective jak-1 inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic dmards

OP0334 Efficacy and safety of continuing versus withdrawing adalimumab (ADA) in maintaining remission in patients with non-radiographic axial spondyloarthritis (NR-AXSPA)

SAT0255 Patient reported outcomes of upadacitinib: results from biologic inadequate responders (SELECT BEYOND PHASE III TRIAL)

OP0035 Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate

SAT0254 Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs: results from select-next

SAT0219 Upadacitinib in patients with active rheumatoid arthritis and inadequate response or intolerance to biological dmards: a phase 3 randomized, placebo-controlled, double-blind study of a selective jak1 inhibitor

Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis

FRI0438 Disease management of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients is similar in academic and community practice among 654 surveyed rheumatologists

FRI0440 Referral patterns and diagnosis of patients with axial spondyloarthritis: results of an international survey

AB1158 Quality of Life in Patients with Active Peripheral SPA is Similarly Impaired as in Other Rheumatic Diseases and Influenced by Disease Activity But not Disease Duration

THU0359 Smoking was not Associated with Response to Adalimumab Therapy in Patients with Non-Radiographic Axial Spondyloarthritis

SAT0339 Asas40 and ASDAS Responses Are Associated with Improved Physical Function, Hrqol, and Work Productivity in Patients with Non-Radiographic Axial Spondyloarthritis

OP0109 Sustained Clinical Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Two Years of Adalimumab Treatment

THU0361 Relationship between MRI and Clinical Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Two Years of Adalimumab Therapy

FRI0425 Similar levels of disease activity in patients with oligoarticular vs. polyarticular peripheral spondyloarthritis

Application of Retort Pouch Sterilization Technology to DD Satoe Packaged Chili Sauce Surabaya

OP0105 Effect of Adalimumab on Physical Function, Health-Related Quality of Life, and Work Productivity in Patients with Peripheral Spondyloarthritis: Results from the Ability-2 Clinical Trial

PREFERENSI KONSUMEN TERHADAP EMPAT VARIETAS UNGGUL MANGGA INDONESIA BERDASARKAN RESPON EMOSI

KARAKTERISTIK FISIKOKIMIA DAN SENSORI BERAS ANALOG MULTIGRAIN BERPROTEIN TINGGI

KARAKTERISASI KEJU DANGKE MENGGUNAKAN ENZIM PAPAIN KOMERSIAL DAN PERUBAHAN FISIK SELAMA PENYIMPANAN

ISOLASI PROTEIN KACANG MERAH DAN KACANG HIJAU MENGGUNAKAN METODE ASAM BASA DIKOMBINASIKAN DENGAN PROSES ENZIMATIS

Suchergebnisse filtern